(Q47281728)

13 January 2018

title

Body weight does not predict for anti-Xa levels after fixed dose prophylaxis with enoxaparin after orthopedic surgery (English)

1 reference

13 January 2018

author name string

Kovacs MJ

1

1 reference

13 January 2018

Weir K

2

1 reference

13 January 2018

MacKinnon K

3

1 reference

13 January 2018

Keeney M

4

1 reference

13 January 2018

Brien WF

5

1 reference

13 January 2018

Cruickshank MK

6

1 reference

13 January 2018

publication date

1 August 1998

1 reference

13 January 2018

published in

Thrombosis Research

1 reference

13 January 2018

volume

91

1 reference

13 January 2018

issue

3

1 reference

13 January 2018

page(s)

137-142

1 reference

13 January 2018

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

LMW heparin (anti-Xa) assays for clinical monitoring and pharmacokinetic studies on the automated coagulation laboratory (ACL)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either logiparin® (LMWH) or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

Monitoring the anticoagulant effects of a low molecular weight heparin preparation. Correlation of assays in orthopedic surgery patients receiving ardeparin sodium for prophylaxis of deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

Low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900083-8

7 January 2021

10.1016/S0049-3848(98)00083-8

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

9733157

1 reference

13 January 2018